Publication Cover
Aging, Neuropsychology, and Cognition
A Journal on Normal and Dysfunctional Development
Volume 23, 2016 - Issue 5
657
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Examining the reliability of ADAS-Cog change scores

, &
Pages 513-529 | Received 20 May 2015, Accepted 27 Nov 2015, Published online: 28 Dec 2015

References

  • Allen, M. J., & Yen, W. M. (2001). Introduction to measurement theory. Long Grove, IL: Waveland Press.
  • Brennan, R. L. (2010). Generalizability theory. New York, NY: Springer.
  • Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334. doi:10.1007/BF02310555
  • Cronbach, L. J., & Furby, L. (1970). How we should measure “change”: Or should we? Psychological Bulletin, 74, 68–80. doi:10.1037/h0029382
  • Cronbach, L. J., Gleser, G., Nanda, H., & Rajaratnam, N. (1972). The dependability of behavioral measurements: Theory of generalizability for scores and profiles. New York, NY: Wiley.
  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198. doi:10.1016/0022-3956(75)90026-6
  • Joe, G. W., & Woodward, J. A. (1976). Some developments in multivariate generalizability. Psychometrika, 41, 205–217. doi:10.1007/BF02291839
  • Kane, M. (1996). The precision of measurements. Applied Measurement in Education, 9, 355–379. doi:10.1207/s15324818ame0904_4
  • Mecocci, P., Bladström, A., & Stender, K. (2009). Effects of memantine on cognition in patients with moderate to severe Alzheimer’s disease: Post-hoc analyses of ADAS-Cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies. International Journal of Geriatric Psychiatry, 24, 532–538. doi:10.1002/gps.2226
  • Mega, M. S., Dinov, I. D., Porter, V., Chow, G., Reback, E., Davoodi, P., … Cummings, J. L. (2005). Metabolic patterns associated with the clinical response to galantamine therapy: A fludeoxyglucose f 18 positron emission tomographic study. Archives of Neurology, 62, 721–728. doi:10.1001/archneur.62.5.721
  • Miller, T. B., & Kane, M. (2001). The precision of change scores under absolute and relative interpretations. Applied Measurement in Education, 14, 307–327. doi:10.1207/S15324818AME1404_1
  • Mohs, R. C., Knopman, D., Petersen, R. C., Ferris, S. H., Ernesto, C., Grundman, M., … Thai, L. J. (1997). Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer’s disease assessment scale that broaden its scope. Alzheimer Disease & Associated Disorders, 11, 13–21. doi:10.1097/00002093-199700112-00003
  • Pyo, G., Elble, R. J., Ala, T., & Markwell, S. J. (2006). The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale. Alzheimer Disease & Associated Disorders, 20, 16–22. doi:10.1097/01.wad.0000201846.22213.76
  • R Core Team. (2014). R: A language and environment for statistical computing [Computer Software Manual]. Vienna, Austria: R Foundation for Statistical Computing. Retrieved from http://www.R-project.org/
  • Rey, A. (1941). L’examen psychologique dans les cas d’encéphalopathie traumatique. Archives de Psychologie, 28, 215–285.
  • Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer’s disease. The American Journal of Psychiatry, 141, 1356–1364. doi:10.1176/ajp.141.11.1356
  • Schrag, A., Schott, J., & Alzheimer’s Disease Neuroimaging Initiative. (2012). What is the clinically relevant change on the ADAS-Cog? Journal of Neurology, Neurosurgery & Psychiatry, 83, 171–173. doi:10.1136/jnnp-2011-300881
  • Skinner, J., Carvalho, J. O., Potter, G. G., Thames, A., Zelinski, E., Crane, P. K., … Gibbons, L. E. (2012). The Alzheimer’s disease assessment scale-cognitive-plus (ADAS-Cog-plus): An expansion of the adas-cog to improve responsiveness in mci. Brain Imaging and Behavior, 6, 489–501. doi:10.1007/s11682-012-9166-3
  • Weyer, G., Erzigkeit, H., Kanowski, S., Ihl, R., & Hadler, D. (1997). Alzheimer’s disease assessment scale: Reliability and validity in a multicenter clinical trial. International Psychogeriatrics, 9, 123–138. doi:10.1017/S1041610297004298
  • Winblad, B., Brodaty, H., Gauthier, S., Morris, J. C., Orgogozo, J.-M., Rockwood, K., … Wilkinson, D. (2001). Pharmacotherapy of Alzheimer’s disease: Is there a need to redefine treatment success? International Journal of Geriatric Psychiatry, 16, 653–666. doi:10.1002/gps.496

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.